Metabolic targeting synergizes with MAPK inhibition and delays drug resistance in melanoma

201845 citationsJournal Article

Authors

Good health and well-being

Published in: Cancer Letters

Volume 442, pp. 453-463

Field-Weighted Citation Impact: 1.95